Health-related quality of life in metastatic and adjuvant breast cancer patients

Geburtshilfe und Frauenheilkunde

Volumn 76, Issue 10, 2016, Pages 1065-1073

  Wallwiener, M ^a   Simoes, E ^b   Sokolov, A N ^b   Brucker, S Y ^b   Fasching, P A ^c   Graf, J ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

breast cancer; EORTC QLQ C30; HRQL; metastatic and adjuvant setting; PRO

Indexed keywords

ADULT; AGED; APPETITE DISORDER; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIARRHEA; DYSPNEA; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTATIC BREAST CANCER; MIDDLE AGED; NAUSEA; PAIN; POPULATION; QUALITY OF LIFE; QUESTIONNAIRE; SLEEP DISORDER; VOMITING;

EID: 84992134129     PISSN: 00165751     EISSN: 14388804     Source Type: Journal    
DOI: 10.1055/s-0042-113188     Document Type: Article

References (40)

1. Rhiem K., Schmutzler R. K. Risikofaktoren und Prävention des Mammakarzinoms. Onkologe: 2015; 21 202 210
2. RKI (Robert Koch-Institut) Krebs in Deutschland 2009/2010. Berlin: 2015; Online: http://www.krebsdaten.de/Krebs/DE/Content/Publikationen/Krebs-in-Deutschland/kid-2015/krebs-in-deutschland-2015.pdf?-blob=publicationFile last access: 01.04.2016
3. RKI (Robert Koch-Institut) Zentrum für Krebsregisterdaten Brustkrebs (Mammakarzinom). Online: http://www.krebsdaten.de/Krebs/DE/Content/Krebsarten/Brustkrebs/brustkrebs-node.html last access: 10.03.2016
4. Gondos A., Bray F., Hakulinen T. et al. Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol: 2009; 20 564 573
5. Kunze U. Mammakarzinom: Epidemiologie und Risikofaktoren. J Gastroenterol Hepatol Erkr: 2011; 9 38 40
6. Cady B. Local therapy and survival in breast cancer. N Engl J Med: 2007; 357 1051 1052 author reply 1052
7. Heil J., Gondos A., Rauch G. et al. Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit. Breast: 2012; 21 303 308
8. Jemal A., Siegel R., Xu J. et al. Cancer statistics, 2010. CA Cancer J Clin: 2010; 60 277 300
9. MacMahon B. Epidemiology and the causes of breast cancer. Int J Cancer: 2006; 118 2373 2378
10. De Grève J., Sermijn E., De Brakeleer S. et al. Hereditary breast cancer: from bench to bedside. Curr Opin Oncol: 2008; 20 605 613
11. Hamilton R. Genetics: breast cancer as an exemplar. Nurs Clin North Am: 2009; 44 327 338
12. Schneeweiss A., Ruckhäberle E., Huober J. Chemotherapie des metastasierten Mammakarzinoms - ein Anachronismus in der Ära der personalisierten, zielgerichteten onkologischen Therapie? Geburtsh Frauenheilk: 2015; 75 574 583
13. Dufresne A., Pivot X., Tournigand C. et al. Impact of chemotherapy beyond the first line in patients with metastatic breast cancer. Breast Cancer Res Treat: 2008; 107 275 279
14. Cortés J., Baselga J., Im Y. H. et al. Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. Ann Oncol: 2013; 24 2630 2635
15. Martino M., Ballestrero A., Zambelli A. et al. Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry. Bone Marrow Transplant: 2015; 48 414 418
16. Jackisch C. Metastasiertes Mammakarzinom: Längeres und besseres Überleben. Dtsch Arztebl: 2014; 111 18 23
17. Cetin K., Christiansen C. F., Sværke C. et al. Survival in patients with breast cancer with bone metastasis: a Danish population-based cohort study on the prognostic impact of initial stage of disease at breast cancer diagnosis and length of the bone metastasis-free interval. BMJ Open: 2015; 5 e007702
18. Ahn S. G., Lee H. M., Cho S. H. et al. Prognostic factors for patients with bone-only metastasis in breast cancer. Yonsei Med J: 2013; 54 1168 1177
19. RKI (Robert Koch-Institut) Gesundheitsbezogene Lebensqualität. Online: http://www.rki.de/DE/Content/Gesundheitsmonitoring/Gesundheitsberichterstattung/GesundAZ/Content/G/Gesbez-Lebensqualitaet/Gesbez-Lebensqualitaet.html last access: 10.01.2016
20. Radoschewski M. Gesundheitsbezogene Lebensqualität - Konzepte und Maße. Bundesgesundheitsbl Gesundheitsforschung Gesundheitsschutz: 2000; 43 165 189
21. Kemmler G., Holzner B., Kopp M. et al. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30. J Clin Oncol: 1999; 17 2932 2940
22. Stephens C., Alpass F., Baars M. et al. SF-36v2 norms for New Zealanders aged 55-69 years. N Z Med J: 2010; 123 1 11
23. Laguardia J., Campos M. R., Travassos C. M. et al. Psychometric evaluation of the SF-36 (v.2) questionnaire in a probability sample of Brazilian households: results of the survey Pesquisa Dimensoes Sociais das Desigualdades (PDSD), Brazil, 2008. Health Qual Life Outcomes: 2011; 9 61
24. Ellert U., Kurth B. M. Gesundheitsbezogene Lebensqualität bei Erwachsenen in Deutschland. Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1). Bundesgesundheitsbl Gesundheitsforschung Gesundheitsschutz: 2013; 56 643 649
25. IQWiG (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen) Allgemeine Methoden, 2008, S. 31. Online: https://www.iqwig.de/download/IQWiG-Methoden-Version-3-0.pdf last access: 09.01.2016
26. (Gemeinsamer Bundesausschuss) G-BA Verfahrensordnung des Gemeinsamen Bundesausschusses. Stand: 21.06.2012, S. 30. Online: https://www.g-ba.de/downloads/62-492-634/VerfO-2012-06-21.pdf last access: 09.01.2016
27. Perry S., Kowalski T. L., Chang C. H. Quality of life assessment in women with breast cancer: benefits, acceptability and utilization. Health Qual Life Outcomes: 2007; 5 24
28. Koch L., Jansen L., Herrmann A. et al. Quality of life in long-term breast cancer survivors - a 10-year longitudinal population-based study. Acta Oncol: 2013; 52 1119 1128
29. Alzabaidey F. J. Quality of life assessment for patients with breast cancer receiving adjuvant therapy. J Cancer Sci Ther: 2012; 4 051 055
30. Karamouzis M. V., Ioannidis G., Rigatos G. Quality of life in metastatic breast cancer patients under chemotherapy or supportive care: a single-institution comparative study. Eur J Cancer Care (Engl): 2007; 16 433 438
31. Kyrgidis A., Triaridis S., Kontos K. et al. Quality of life in breast cancer patients with bisphosphonate-related osteonecrosis of the jaws and patients with head and neck cancer: a comparative study using the EORTC QLQ-C30 and QLQ-HN35 questionnaires. Anticancer Res: 2012; 32 3527 3534
32. Korpela J., Mali P., Kaljonen A. et al. Quality of life of patients with metastatic breast cancer treated with epirubicin and docetaxel. Int J Clin Med: 2011; 2 346 351
33. Aaronson N. K., Ahmedzai S., Bergman B. et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer I: 1993; 85 365 376
34. Nguyen J., Popovic M., Chow E. et al. EORTC QLQ-BR23 and FACT-B for the assessment of quality of life in patients with breast cancer: a literature review. J Comp Eff Res: 2015; 4 157 166
35. Greiner W., Claes C., Busschbach J. J. et al. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ: 2005; 6 124 130
36. EORTC data center EORTC QLQ C-30 Scoring Manual. 3rd ed. Brussels Eigenverlag: 2001; Online: https://wiki.nci.nih.gov/download/attachments/167543767/EORTC-QLQ-C30%20-scoring-Manual.pdf last access: 10.01.2016
37. Van Reenen M., Janssen B. EQ-5D-5L User Guide. Basic information and how to use the EQ-5D-5L instrument. 2015; Online: http://www.euroqol.org/fileadmin/user-upload/Documenten/PDF/Folders-Flyers/EQ-5D-5L-UserGuide-2015.pdf last access: 12.01.2016
38. Hinz A., Singer S., Brahler E. European reference values for the quality of life questionnaire EORTC QLQ-C30: results of a German investigation and a summarizing analysis of six European general population normative studies. Acta Oncol: 2014; 53 958 965
39. NIH National Cancer Institute Adjuvant and neoadjuvant therapy for breast cancer. 2009; Online: http://www.cancer.gov/types/breast/adjuvant-fact-sheet last access: 01.02.2016
40. Bernhard J., Luo W., Ribi K. et al. Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials. Lancet Oncol: 2015; 16 848 858